Researchers from NIH identify sources of bias in previous studies, suggesting strategies to reduce severe influenza outcomes among the elderly. The authors emphasize the need for better flu vaccines and new approaches, including antiviral drugs and targeted vaccination for high-risk individuals.
SourceNIH/National Institute of Allergy and Infectious Diseases·JournalThe Lancet Infectious Diseases·DateSep 24, 2007
The Lancet Infectious Diseases report highlights frailty selection bias and non-specific trial endpoints as reasons behind the exaggeration. Few trials have included elderly people, especially those aged at least 70 years, which accounts for three-quarters of all influenza-related deaths.
SourceThe Lancet_DELETED·JournalThe Lancet Infectious Diseases·DateSep 24, 2007
Apple iPhone 17 Pro
Apple iPhone 17 Pro delivers top performance and advanced cameras for field documentation, data collection, and secure research communications.
A new study published in Pediatrics found that annual flu shots significantly reduce outpatient visits and hospitalizations due to flu-related illness. Vaccinating half of U.S. children could prevent up to 650,000 doctor's office visits and 2,250 hospitalizations per year.
SourceMassachusetts General Hospital·JournalPEDIATRICS·DateSep 4, 2007
Researchers developed a novel antigen-sparing adjuvant strategy to improve immunogenicity of the bird flu vaccine. The new formulation showed significant cross-clade immunity against H5N1 viruses and induced high levels of neutralizing antibodies, increasing protection against pandemic.
A new study by the New York Academy of Medicine highlights the critical need to address vaccination coverage among hard-to-reach populations. The authors propose achievable strategies to increase immunization rates among these groups, including unconventional site distribution and patient reminders.
SourceNew York Academy of Medicine·JournalJournal of Urban Health·DateAug 15, 2007
A national survey found gaps in vaccine financing for underinsured children, leading to concerns about access to life-saving vaccinations like pneumococcal conjugate and meningococcal conjugate vaccines. The study highlights the need for improved funding and distribution of new pediatric vaccines at the state level.
Researchers at The Wistar Institute discovered a mechanism where the gene-transcription machinery can be paused by the ubiquitin molecule until a triggering signal is received. This pause allows for quick activation of genes in response to stress or vital needs, such as stem-cell differentiation.
SourceThe Wistar Institute·JournalMolecular Cell·DateJul 25, 2007
SAMSUNG T9 Portable SSD 2TB
SAMSUNG T9 Portable SSD 2TB transfers large imagery and model outputs quickly between field laptops, lab workstations, and secure archives.
Two new studies emphasize the importance of delivering measles and influenza vaccines to HIV-infected individuals. Measles vaccine administered at age 9 months showed limited protection in HIV-infected children, highlighting the need for supplementary vaccinations to maintain immunity. In contrast, rates of influenza vaccination among ...
SourceInfectious Diseases Society of America·JournalThe Journal of Infectious Diseases·DateJul 23, 2007
Scientists are testing a universal flu vaccine that targets all 'A' strains of the virus, offering broad and lifelong protection. The vaccine has shown promising results in laboratory animals and is now being administered to a small group of healthy people in Phase I clinical trials.
SourceVIB (the Flanders Institute for Biotechnology)·DateJul 17, 2007
A study predicts that using Tamiflu prophylactically could reduce illness and death rates during an influenza pandemic by half, with a cost savings of $70,000 per 1,000 population. Prophylaxis with antivirals or vaccines is considered a crucial strategy in the early months of a pandemic.
Researchers detected anti-Fluzone antibodies in 40% of cord blood specimens, establishing B and T cell responses to antigens occur in utero following maternal vaccination. This finding has significant implications for understanding when immune responses to environmental exposures begin.
SourceJCI Journals·JournalJournal of Clinical Investigation·DateJun 1, 2007
Research highlights the influence of private hospital care on Medicaid patients, flu vaccine shortages, and smoking bans on health outcomes. Smoking bans at home and work significantly improve health status among nonsmokers, while racial diversity in neighborhoods affects pregnant women's decision to smoke.
SourceNew York Academy of Medicine·JournalJournal of Urban Health·DateMay 14, 2007
Sky-Watcher EQ6-R Pro Equatorial Mount
Sky-Watcher EQ6-R Pro Equatorial Mount provides precise tracking capacity for deep-sky imaging rigs during long astrophotography sessions.
Current health policy based on voluntary vaccinations is not enough to control severe flu epidemics and pandemics unless vaccination programs offer incentives to individuals. Free vaccinations for entire families could actually increase the frequency of severe epidemics, according to UCLA researchers.
SourcePLOS·JournalPLOS Computational Biology·DateMay 3, 2007
A new study by UCLA researchers suggests that current US control strategies for flu epidemics may not be effective and could even make outbreaks worse. The study found that providing free vaccinations to entire families can actually increase the frequency of severe epidemics due to decreased adaptability among household members.
SourceUniversity of California - Los Angeles·JournalPLOS Computational Biology·DateMay 3, 2007
A national study led by Saint Louis University School of Medicine is investigating the effectiveness of a new investigational vaccine made by Bavarian Nordic in stimulating an immune response against smallpox. The study aims to determine how quickly people can be protected after a release of smallpox into the environment.
Research shows that influenza epidemics are associated with a rise in deaths from heart disease and flu can trigger heart attacks. The study highlights the importance of increasing vaccination rates in people at risk of coronary heart disease.
SourceOxford University Press UK·JournalEuropean Heart Journal·DateApr 17, 2007
Sky & Telescope Pocket Sky Atlas, 2nd Edition
Sky & Telescope Pocket Sky Atlas, 2nd Edition is a durable star atlas for planning sessions, identifying targets, and teaching celestial navigation.
A new experimental flu vaccine made in insect cells has been shown to be safe and effective in protecting against the flu, with a stronger immune response at higher doses. The use of cell culture systems to grow vaccines is a growing business and could potentially slice off months from the production process.
SourceUniversity of Rochester Medical Center·JournalJAMA·DateApr 10, 2007
A new experimental flu vaccine produced using insect cells has shown promising results in early testing, demonstrating safety and immunogenic response in healthy adults. The vaccine, made using recombinant DNA techniques, offers a potential alternative to traditional egg-based vaccines.
The University of Rochester Medical Center has been awarded a $26 million contract to establish the New York Influenza Center of Excellence, one of six nationwide centers focused on improving flu research. The center aims to develop more effective vaccines against seasonal influenza and future pandemics.
SourceUniversity of Rochester Medical Center·DateApr 2, 2007
Historical analyses of the 1918 Spanish influenza pandemic reveal that cities with early public health measures had lower peak weekly death rates and overall mortality compared to those that waited. Implementing multiple social containment measures within a few days of first local cases recorded cut peak death rates by up to half.
SourceNIH/National Institute of Allergy and Infectious Diseases·JournalProceedings of the National Academy of Sciences·DateApr 2, 2007
A new UCLA study found that practicing Tai Chi chih alone boosts immunity to a level comparable to the standard vaccine against shingles. Combining Tai Chi with the vaccine results in a clinically relevant boost and added benefits for middle-aged adults.
SourceUniversity of California - Los Angeles·JournalJournal of the American Geriatrics Society·DateMar 22, 2007
Rigol DP832 Triple-Output Bench Power Supply
Rigol DP832 Triple-Output Bench Power Supply powers sensors, microcontrollers, and test circuits with programmable rails and stable outputs.
Developing an H5 vaccine faces hurdles in current egg production methods and the molecule's ability to stimulate an immune reaction, requiring two shots for full immunization. The ideal adjuvant must still be found to boost vaccine effectiveness.
Developing countries face a critical shortage of pandemic influenza vaccines, with only 500 million doses available globally. The WHO is urging international agreement to ensure affordable vaccine access for these nations, demonstrating global solidarity in the face of the next pandemic threat.
A recent global study found that a nasal spray flu vaccine reduced the attack rate of flu in children by 55 percent compared to traditional flu shots. The vaccine was well-tolerated and induced a more complete immune response, with fewer ear infections reported.
SourceSaint Louis University·JournalNew England Journal of Medicine·DateFeb 14, 2007
Researchers at St. Jude Children's Research Hospital found that the N1 protein in seasonal flu vaccines can trigger an antibody response to avian flu virus, offering cross-protection to some individuals. The study suggests that annual influenza vaccines may be beneficial to populations in areas where H5N1 poses a threat to humans.
SourceSt. Jude Children's Research Hospital·JournalPLOS Medicine·DateFeb 13, 2007
Creality K1 Max 3D Printer
Creality K1 Max 3D Printer rapidly prototypes brackets, adapters, and fixtures for instruments and classroom demonstrations at large build volume.
A human trial of a DNA vaccine designed to prevent H5N1 avian influenza infection began in December 2006. The vaccine instructs human cells to make proteins that act as a vaccine against the virus, providing broad immune responses without infectious material.
SourceNIH/National Institute of Allergy and Infectious Diseases·DateJan 3, 2007
A futures market for influenza activity has been created, predicting outbreaks two to four weeks in advance with high accuracy. The market aggregates expert opinions of healthcare providers, allowing for real-time analysis and informed decision-making in public health.
SourceInfectious Diseases Society of America·JournalClinical Infectious Diseases·DateDec 21, 2006
A University of Michigan study found that the traditional flu shot was effective in preventing influenza in healthy adults, while the live attenuated-virus nasal spray vaccine was less effective. The study compared the two vaccines head-to-head with laboratory confirmation and found significant differences in their protective effects.
SourceUniversity of Michigan·JournalNew England Journal of Medicine·DateDec 13, 2006
The 2004 influenza vaccine shortage had a significant impact on continuity of care, with flu vaccination rates dropping by over 50% in some areas. Additionally, studies found that improper antibiotic use can exacerbate sinusitis symptoms and that patients with sore throats often seek pain relief rather than antibiotics.
SourceAmerican Academy of Family Physicians·JournalThe Annals of Family Medicine·DateDec 5, 2006
A federal plan to vaccinate healthcare workers against smallpox had a low compliance rate and high variability among states. Researchers found that some states ranked poorly due to lack of support and ambivalent messages from authorities.
SourceTemple University·JournalEpidemiology and Infection·DateNov 29, 2006
Kestrel 3000 Pocket Weather Meter
Kestrel 3000 Pocket Weather Meter measures wind, temperature, and humidity in real time for site assessments, aviation checks, and safety briefings.
A powerful analysis reveals that only one-third of high-risk populations in Europe receive seasonal influenza vaccine, resulting in avoidable morbidity and mortality. Implementing EU vaccination recommendations could reduce the number of cases of death and illness from influenza, as well as contribute to flu pandemic preparedness.
A RAND Corporation study found that nursing homes with high staff and resident vaccination rates are less likely to experience flu outbreaks. Vaccination rates of over 55% for staff and 89% for residents were associated with a 60% reduction in influenza-like illness cases.
SourceRAND Corporation·JournalJournal of the American Medical Directors Association·DateNov 15, 2006
The U.S. Vaccine and Infectious Disease Organization has discovered a crucial pathway that supports the influenza A virus's ability to reproduce itself. This finding could lead to the development of new live vaccines and antiviral drugs for influenza epidemics and pandemics.
SourceCanadian Institutes of Health Research·JournalJournal of General Virology·DateNov 15, 2006
Garmin GPSMAP 67i with inReach
Garmin GPSMAP 67i with inReach provides rugged GNSS navigation, satellite messaging, and SOS for backcountry geology and climate field teams.
A Canadian study found that flu vaccines are associated with a small but increased risk of hospitalization for Guillain-Barré syndrome, a potentially debilitating neurological disorder. The absolute risk is very low, and the disorder affects about one in 100,000 individuals per year.
SourceJAMA Network·JournalArchives of Internal Medicine·DateNov 13, 2006
A large safety study found that the flu vaccine is not associated with an increased risk of serious conditions in young children. The study analyzed data on over 45,000 children who received the trivalent inactivated influenza vaccine between 1991 and 2003.
Scientists have developed a vaccine that protects mice against the 1918 influenza virus, which killed 50 million people worldwide. The vaccine works by stimulating antibodies capable of neutralizing the virus, providing a potential solution to future pandemic flu strains.
SourceNIH/National Institute of Allergy and Infectious Diseases·JournalProceedings of the National Academy of Sciences·DateOct 17, 2006
A booster shot given before a primary immunization may protect people against bird flu. Studies in Rochester suggest that adults who have never encountered the virus would benefit from an additional dose.
SourceUniversity of Rochester Medical Center·DateOct 12, 2006
Researchers found that a prime-boost strategy using different subtypes of H5N1 vaccines significantly boosted immune responses in individuals with prior exposure. Additionally, an intradermal approach to delivering the vaccine showed promise but did not improve the immune response. These findings suggest pre-pandemic priming with exist...
SourceNIH/National Institute of Allergy and Infectious Diseases·JournalVaccine·DateOct 12, 2006
Celestron NexStar 8SE Computerized Telescope
Celestron NexStar 8SE Computerized Telescope combines portable Schmidt-Cassegrain optics with GoTo pointing for outreach nights and field campaigns.
The Journal of Infectious Diseases has published a supplement offering current information on pandemic and seasonal influenza, featuring leading experts discussing research and recommendations. The article highlights key findings on disease surveillance, vaccine manufacturing, and public health response plans.
SourceInfectious Diseases Society of America·JournalThe Journal of Infectious Diseases·DateOct 5, 2006
A new study by mathematical biologists at The University of Texas at Austin recommends vaccine distribution strategies for potential shortages. The best approach depends on the contagiousness of the flu strain, with school children and high-risk groups being prioritized accordingly.
SourceUniversity of Texas at Austin·JournalPLOS Medicine·DateOct 2, 2006
Researchers found that KEAP1 mutations in lung cancer cells increase NRF2 activity, leading to chemotherapy resistance. Meanwhile, a new study suggests targeting school-aged children for flu vaccination could help contain outbreaks.
A clinical trial has demonstrated the efficacy of an H9N2 avian flu vaccine combined with an adjuvant in generating a strong antibody response in humans. The results suggest that even low doses of the vaccine can provide protection, making it a promising tool in pandemic prevention.
SourceNIH/National Institute of Allergy and Infectious Diseases·JournalClinical Infectious Diseases·DateSep 25, 2006
Apple MacBook Pro 14-inch (M4 Pro)
Apple MacBook Pro 14-inch (M4 Pro) powers local ML workloads, large datasets, and multi-display analysis for field and lab teams.
Researchers have achieved effective immunity with a low dose of bird flu vaccine using MF59 adjuvant, potentially stretching vaccine supply. The study showed that antibody levels were significantly better and that a single dose of the adjuvanted vaccine was as good as two doses without adjuvant.
SourceInfectious Diseases Society of America·JournalClinical Infectious Diseases·DateSep 25, 2006
Researchers propose using existing facilities to produce vaccines from cell cultures, which could make enough doses to cover the US in just 3-4 months. This approach would reduce downtime and capital investments required for new dedicated facilities.
Researchers developed live attenuated vaccines using weakened influenza virus proteins and found they elicited broad and lasting immunity in mice and ferrets. The vaccines provided protection against different H5N1 viruses that emerged years later, demonstrating potential as a future treatment option for avian flu.
GoPro HERO13 Black
GoPro HERO13 Black records stabilized 5.3K video for instrument deployments, field notes, and outreach, even in harsh weather and underwater conditions.
A new H5N1 influenza vaccine has produced a safe and effective immune response in healthy people at low doses, with the highest dose showing the best response. The vaccine was well-tolerated and did not have significantly more side effects compared to a placebo.
SourceThe Lancet_DELETED·JournalThe Lancet·DateSep 6, 2006
The University of Pittsburgh School of Medicine has received a $1.3 million grant to produce a promising avian flu vaccine that could protect against the deadly H5N1 virus. The vaccine, developed by Dr. Andrea Gambotto's team, has shown complete protection in mice and chickens against infection.
SourceUniversity of Pittsburgh Medical Center·DateAug 28, 2006
Researchers at MSU have developed a new cell line that can grow nearly all types of flu viruses, potentially leading to faster and cheaper vaccine production. This could help address the issues with traditional influenza vaccine production methods, including long production times and limited supply.
CalDigit TS4 Thunderbolt 4 Dock
CalDigit TS4 Thunderbolt 4 Dock simplifies serious desks with 18 ports for high-speed storage, monitors, and instruments across Mac and PC setups.
A new H5N1 vaccine has demonstrated cross-protection in ferrets against different variants of the virus, offering a promising solution for stockpiling in the event of a human outbreak. The vaccine was shown to completely protect ferrets from infection and reduce viral multiplication.
SourceSt. Jude Children's Research Hospital·JournalThe Journal of Infectious Diseases·DateJun 19, 2006
A new experimental vaccine has shown significant protective effects against multiple H5N1 strains in lab animals. The two-dose vaccination schedule induced higher levels of antibodies that were cross-reactive to various viruses, suggesting a potential solution for stockpiling vaccines during pandemics.
SourceInfectious Diseases Society of America·JournalThe Journal of Infectious Diseases·DateJun 13, 2006
Researchers suggest that cholesterol-lowering drugs like statins could be useful in treating and preventing severe complications of the flu during a pandemic. Statins have anti-inflammatory and immunomodulatory effects that may also benefit people with influenza, making them a potential alternative to vaccines.
SourceInfectious Diseases Society of America·JournalClinical Infectious Diseases·DateJun 13, 2006
Researchers report improved survival rates with RP101, a novel compound being investigated as a potential therapeutic for advanced pancreatic cancer. In two studies, patients showed significant improvements in median survival and time to progression, offering hope for patients affected by the disease.
DJI Air 3 (RC-N2)
DJI Air 3 (RC-N2) captures 4K mapping passes and environmental surveys with dual cameras, long flight time, and omnidirectional obstacle sensing.
A new study explores how people make medical decisions, revealing that stepping into others' shoes can lead to better choices. By considering multiple perspectives, including those of doctors, parents, and medical directors, participants made treatment decisions that were more informed than their own self-interest would suggest.
SourceMichigan Medicine - University of Michigan·JournalJournal of General Internal Medicine·DateMay 31, 2006
A study found that higher dose flu vaccines significantly enhanced protection against naturally occurring influenza, increasing immunogenicity in the elderly. The research also showed that all three vaccine dosage levels were safe and well-tolerated.
SourceJAMA Network·JournalArchives of Internal Medicine·DateMay 22, 2006
A two-dose regimen of the H5N1 vaccine induced the highest antibody response after 42 days, with all formulations well-tolerated. However, the level of post-vaccination antibodies needed for protection against the H5 N1 virus remains unknown.
Aranet4 Home CO2 Monitor
Aranet4 Home CO2 Monitor tracks ventilation quality in labs, classrooms, and conference rooms with long battery life and clear e-ink readouts.
Five Spanish hospitals are participating in a phase III trial for an H5N1 influenza pandemic vaccine, alongside countries such as Germany, Holland, and France. The vaccine uses fractionated viral proteins and an adjuvant to stimulate the immune system, with the goal of improving vaccine production strategies.
SourceIDIBAPS - Institut d'Investigacions Biomèdiques August Pi i Sunyer·DateMay 4, 2006
A new study by St. Jude Children's Research Hospital has shown a DNA-based vaccine to be highly effective in protecting mice against lethal challenges with the H5N1 avian influenza virus. The vaccine targets two conserved viral proteins and one variable protein, providing complete protection in mice.
SourceSt. Jude Children's Research Hospital·DateMay 2, 2006
A recent study found that an intranasal influenza vaccine was significantly more effective in protecting young children against flu infection than traditional injections. The vaccine, known as CAIV-T, was 55% more effective in reducing influenza-like illness in children.
A new potential vaccine against deadly leishmaniasis has been developed by a research group led by Peter H. Seeberger, combining a virosome delivery system with a synthetic carbohydrate antigen. This innovative approach aims to overcome the limitations of existing vaccines and provide a strong protective action against the disease.
SourceAmerican Chemical Society·JournalACS Chemical Biology·DateApr 21, 2006
Meta Quest 3 512GB
Meta Quest 3 512GB enables immersive mission planning, terrain rehearsal, and interactive STEM demos with high-resolution mixed-reality experiences.
The American College of Physicians emphasizes the need for a comprehensive healthcare response to pandemic influenza, highlighting the critical role of primary care physicians. The organization recommends hands-on clinical training for internists to address public health crises like pandemic influenza.
SourceAmerican College of Physicians·JournalAnnals of Internal Medicine·DateApr 3, 2006